Anna Kim, MD
MOHS-Micrographic Surgery · Duluth, GANPI 1063869352
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 38.4% of the total. Reporting peaked in 2024 at $628 and has fallen 58.7% since, to $259 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in GA, where the typical reported total is $3,443.
Across 59 payments — averaging $23.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$522
- Sanofi$261
- LEO Pharma Inc.$175
- Johnson & Johnson$82
- Incyte Corporation$72
- UCB, Inc.$66
- plus $181 from 9 others
What the payments were for
- Food & beverage$1,359100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $522 |
| Sanofi | 8 | $261 |
| LEO Pharma Inc. | 7 | $175 |
| Johnson & Johnson | 4 | $82 |
| Incyte Corporation | 4 | $72 |
| UCB, Inc. | 2 | $66 |
| Novartis | 1 | $28 |
| Boehringer Ingelheim | 1 | $28 |
| Organon | 1 | $27 |
| Lilly USA, LLC | 1 | $19 |
| Mimedx Group, Inc. | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Botanix SB Inc | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Almirall LLC | 1 | $13 |
How this compares
$1,359 in reported general payments places this provider in the 25th percentile of 40 mohs-micrographic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 66 | $486 |
| Ketoconazole | 21 | $284 |
| Mupirocin | 32 | $259 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $151 |
| Triamcinolone Acetonide | 11 | $136 |
| Cephalexin | 38 | $79 |
| Tramadol Hcl | 22 | $20 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Duluth
- Brandon BurrowayDuluth$30K
- David PharisDuluth$224
- Wallace NozileStockbridge$213K
- John KayalMarietta$27K
- David HarveyNewnan$17K
- David OlanskyAtlanta$13K
- David KentMacon$11K
- Diamondis PapadopoulosAtlanta$9K
- Sidney SmithSavannah$9K
- Steven KentMacon$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.